参考文献[1]NCCN. Non-Small Cell Lung Cancer clinical practice guidelines in oncology(version 5.2022)[EB/OL].(2022-09-26)[2022-11-11]. https://nccn.medlive.cn/guide/detail/228.[2]中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会 (CSCO) 非小细胞肺癌诊疗指南2022[M]. 北京: 人民卫生出版社, 2022:29-113.[3] MA X H, GUO K, DONG W L, et al. [Efficacy and safety of paclitaxel liposomes compared to paclitaxel combined with platinum in concurrent chemoradiotherapy for unresectable cervical carcinoma: a Meta-analysis]. Zhonghua Zhong Liu Za Zhi. 2021 Oct 23;43(10):1132-1139. Chinese.[4] ZHANG J, PAN Y, SHI Q, et al. Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first-line treatment of locally advanced or metastatic lung squamous cell carcinoma: A multicenter, randomized, open-label, parallel controlled clinical study. Cancer Commun (Lond). 2022 Jan;42(1):3-16.